| Heading: |
Essential Tremor: Ultrasonics |
| Question ID: |
1746137 |
| UIN: |
17253 |
| House: |
Commons |
| Date tabled: |
2024-12-02 |
| Asking Member ID: |
4787 |
| Asking Member display name: |
James Wild
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
James Wild
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, with reference to NHS England's commissioning guidance entitled Transcranial magnetic resonance guided focused ultrasound thalamotomy for treatment of medication-refractory essential tremor, update |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department has made no assessment of the potential impact of NHS England’s guidance on trends in the number of patients accessing transcranial magnetic resonance. Transcranial magnetic resonance guided focused ultrasound thalamotomy is recommended for... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |